Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands

Scandinavian Journal of Immunology

Volumn 72, Issue 4, 2010, Pages 319-331

  Schulz, U ^a   Kreutz, M ^a   Multhoff, G ^b,c   Stoelcker, B ^d   Kohler M ^a   Andreesen, R ^a   Holler, E ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INTERLEUKIN 10; KLRK1 PROTEIN, HUMAN; MESSENGER RNA; MONOCLONAL ANTIBODY; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; SIGNAL PEPTIDE; ULBP2 PROTEIN, HUMAN;

CELL CULTURE; CYTOTOXICITY; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; K562 CELL LINE; MACROPHAGE; METABOLISM; MONOCYTE; NATURAL KILLER CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-10; K562 CELLS; KILLER CELLS, NATURAL; MACROPHAGES; MONOCYTES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77956335963     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02435.x     Document Type: Article

References (42)

1. Kärre K. Role of target histocompatibility antigen in regulation of natural killer activity: a reevaluation and a hypothesis. In : Callewaert D, Herberman RB, eds. Mechanisms of Cytotoxicity by NK Cells. San Diego : Academic Press, 1985 : 81 91.
2. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004 16 : 626 633.
3. Dupont B, Hsu KC. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunol 2004 16 : 634 643.
4. Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer 2007 97 : 539 542.
5. Pfeiffer M, Schumm M, Feuchtinger T, Dietz K, Handgretinger R, Lang P. Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia. Br J Haematol 2007 138 : 97 100.
6. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002 295 : 2097 2100.
7. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today 2000 21 : 228 234.
8. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 23 : 225 274.
9. Fukami-Kobayashi K, Shiina T, Anzai T et al. Genomic evolution of MHC class I region in primates. Proc Natl Acad Sci U S A 2005 102 : 9230 9234.
10. Vankayalapati R, Garg A, Porgador A et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005 175 : 4611 4617.
11. Rolle A, Mousavi-Jazi M, Eriksson M et al. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 2003 171 : 902 908.
12. Welte SA, Sinzger C, Lutz SZ et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 2003 33 : 194 203.
13. Xu X, Rao G, Gaffud MJ et al. Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer. J Clin Endocrinol Metab 2006 91 : 2704 2712.
14. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999 96 : 6879 6884.
15. Pende D, Rivera P, Marcenaro S et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002 62 : 6178 6186.
16. Salih HR, Antropius H, Gieseke F et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003 102 : 1389 1396.
17. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005 436 : 1186 1190.
18. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996 93 : 12445 12450.
19. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998 279 : 1737 1740.
20. Kloss M, Decker P, Baltz KM et al. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol 2008 181 : 6711 6719.
21. Ebihara T, Masuda H, Akazawa T et al. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 2007 19 : 1145 1155.
22. Nedvetzki S, Sowinski S, Eagle RA et al. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007 109 : 3776 3785.
23. Wang H, Ruan Z, Wang Y et al. MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation. Mol Immunol 2008 45 : 1548 1556.
24. Spaggiari GM, Carosio R, Pende D et al. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001 31 : 1656 1665.
25. Welte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol 2006 7 : 1334 1342.
26. Holler E, Roncarolo MG, Hintermeier-Knabe R et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000 25 : 237 241.
27. Wang XN, Lange C, Schulz U et al. Interleukin-10 modulation of alloreactivity and graft-versus-host reactions. Transplantation 2002 74 : 772 778.
28. Andreesen R, Scheibenbogen C, Brugger W et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 1990 50 : 7450 7456.
29. de Waal MR, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991 174 : 915 924.
30. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997 159 : 4772 4780.
31. Jacobs R, Hintzen G, Kemper A et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001 31 : 3121 3127.
32. Penack O, Gentilini C, Fischer L et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 2005 19 : 835 840.
33. Orsilles MA, Pieri E, Cooke P, Caula C. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. APMIS 2006 114 : 55 60.
34. Koutsonikolis A, Haraguchi S, Brigino EN, Owens UE, Good RA, Day NK. HIV-1 recombinant gp41 induces IL-10 expression and production in peripheral blood monocytes but not in T-lymphocytes. Immunol Lett 1997 55 : 109 113.
35. Barcova M, Kacani L, Speth C, Dierich MP. gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J Infect Dis 1998 177 : 905 913.
36. Brigino E, Haraguchi S, Koutsonikolis A et al. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci U S A 1997 94 : 3178 3182.
37. Blazevic V, Heino M, Lagerstedt A, Ranki A, Krohn KJ. Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996 13 : 208 214.
38. Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E. Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol 2000 74 : 10551 10562.
39. Parato KG, Kumar A, Badley AD et al. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS 2002 16 : 1251 1256.
40. Mavilio D, Lombardo G, Kinter A et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006 203 : 2339 2350.
41. Ward J, Bonaparte M, Sacks J et al. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007 110 : 1207 1214.
42. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006 107 : 159 166.